Search

everythinglearnresearchcommunity

for

Search:↓

Trichogram is useful for diagnosing hair disorders, but newer, non-invasive methods like trichoscopy are becoming more popular due to their sensitivity and ability to monitor treatment responses.

Men with male pattern baldness may be more at risk for severe COVID-19, and anti-androgen treatments could offer protection.

Antiandrogens and androgen inhibitors like spironolactone, finasteride, and dutasteride can treat hair loss and skin conditions, but they have risks and side effects, including potential harm to pregnant women and risks of cancer and heart issues. Herbal remedies also have antiandrogenic effects but lack safety validation.

Male pattern baldness may indicate arterial stiffness in transgender men on long-term testosterone therapy.

Eyelashes are important for looks and eye protection, and more people are treating sparse eyelashes; more research is needed to understand eyelash biology and improve treatments.

PRP may help with hair regrowth in male pattern baldness, but more research is needed.

The document concludes that understanding nail anatomy is key for diagnosing nail diseases, early signs of nail melanoma may allow for less aggressive treatment, and specific genetic mutations are important in thyroid cancer prognosis and treatment.

Minoxidil is effective and safe for female hair loss, with the 5% foam having the fewest side effects.

Male-pattern hair loss is normal, often involves hormone effects on hair follicles, and can be treated with medication or surgery, but new treatments are being researched.

Researchers found potential new targets for treating melanoma and nonmelanoma skin cancers, and identified a possible cause and treatment for male pattern baldness and eczema.

Topical minoxidil can help regrow hair in people with common baldness.

Autologous Regenerative Therapy may improve hair restoration by using stem cells from fat.

Oral minoxidil and growth factors improved hair density and thickness in a girl with hereditary hair loss.

Found key genes affecting hair loss, immune response, and skin development; more research needed for better treatments.

Early-onset male baldness is significantly linked to metabolic syndrome, suggesting those with early baldness should consider preventive treatment to reduce risk.

Alopecia areata, a type of hair loss, may be passed through T cells and has genetic links, while treatments vary in effectiveness. Male pattern baldness can be treated with finasteride and is influenced by androgens in hair follicles.

Lowest effective minoxidil concentration is 1%, but 2% works better for male pattern baldness.

Hormones and genetics play key roles in male and female baldness, which can affect mental health and may be linked to other health issues.

Minoxidil modestly increases hair growth in men with early baldness and is safe to use.

Minoxidil (Rogaine) increased interest in treating male pattern baldness.

Researchers found a new gene area linked to male-pattern baldness, which, along with another gene, significantly increases the risk of hair loss in men.

Finasteride reduces scalp DHT levels, potentially treating male pattern baldness.

High testosterone to epitestosterone ratio in hair could predict male-pattern baldness.

Men who experienced baldness at age 20 may have double the risk of getting prostate cancer.

Certain microRNAs are more common in balding areas and might be involved in male pattern baldness.

Topical minoxidil is safe and effective for some early male-pattern baldness cases.

Korean and Caucasian men with male pattern baldness have different hair steroid levels.

The mouse model suggests male pattern baldness may be due to an enzyme increasing DHT and higher androgen receptor levels in hair follicles.

Finasteride may increase hair growth and prevent baldness in men, but can cause sexual side effects.

Common latent viruses might contribute to male-pattern baldness by disrupting cell processes that normally suppress hair loss-related proteins.